COVID-19 Prevention/Treatments​​​ - Public Information

​Learn about COVID-19 Prevention and Treatments

Pre-Exposure

• Vaccination: Vaccination is the best way to protect against COVID-19 and reduce the risk of hospitalization and death. There are three (3) COVID-19 vaccines available for adults, Janssen, Pfizer, and Moderna. The Pfizer and Moderna vaccines have received full FDA approval. Children ages 5 and up can receive the Pfizer vaccine to protect against COVID-19. You can find a vaccination location nearest you. 
• Evusheld (Tixagevimab/Cilgavimab): Evusheld is a series of two (2) antibody shots. Evusheld is for people who are immune-compromised or who have a history of adverse reactions to vaccines. Adults and children aged 12 years or older who are eligible can receive this. Evusheld is not a treatment for COVID-19. Evusheld should not be given to people testing positive for COVID-19 or who have had a known recent exposure. Evusheld may only be prescribed for people by health care providers. Please see your primary care doctor or go to an urgent care facility for a prescription. Evusheld Fact Sheet​ 

Recent Information on COVID-19 Treatments​

​COVID-19 Therapies Test to Treat Map and Program Information 

• A new web-based COVID-19 Test ​to Treat Locator Map is now available to make it easier to find Test to Treat locations. In the Test to Treat program, people are able to get tested and – if they are positive and treatments are appropriate for them – receive a prescription from a health care provider, and then have their prescription filled all at one location.
  

These products are not a substitute for vaccination against COVID-19 - learn more. 

These treatments require a prescription from your doctor. If you do not have a primary care doctor, please go to an urgent care. Do not approach a pharmacy without a prescription. Do not go to the emergency department of a hospital to obtain a prescription.

• Molnupiravir: Is an oral drug for COVID-positive adults who are at high risk of developing severe disease. Treatment with Molnupiravir should begin within 5 days once symptoms begin. Molnupiravir is not for people younger than 18 years old, or people hospitalized due to COVID-19. Molnupiravir is not recommended for pregnant women. Molnupiravir Fact Sheet 
• Paxlovid: Paxlovid is an oral drug used to treat mild-to-moderate cases of COVID-19 in adults and children 12 years old and up. Paxlovid is not meant for people hospitalized due to COVID-19. Paxlovid Fact Sheet 
• Velkury (Remdesivir): Remdesivir a COVID-19 drug used for hospitalized people aged 12 years or older who are experiencing severe COVID-19. This drug is given through an IV and requires a doctor’s prescription. Remdesivir Fact Sheet 
• Monoclonal Antibody Treatment (Bebtelovimab):  The monoclonal antibody treatment (Bebtelovimab) is available for adults and children aged 12 years or older who are at high risk of progressing to severe COVID-19. This treatment can be given as either a shot or IV drip and should be given within 10 days after developing symptoms. Bebtelovimab is not meant for people hospitalized due to COVID-19. Bebtelovimab Fact Sheet 
  

 January 2022: CDPH Available Outpatient Therapies at Each Stage​

Image:

​

Text of Image​:

COVID-19 Treatment Resource links:

• CDPH: Get the Facts on COVID-19 Treatments (ca.gov)
  
• ​CDPH COVID-19 Treatments Fact Sheet​
  
• US DHHS: COVID-19 Treatments and Therapeutics | HHS.gov
• ​A new web-based COVID-19 Test ​to Treat Locator Map is now available to make it easier to find Test to Treat locations. In the Test to Treat program, people are able to get tested and – if they are positive and treatments are appropriate for them – receive a prescription from a health care provider, and then have their prescription filled all at one location.​
• FDA: Know Your Treatment Options for COVID-19 | FDA​

• CDC: Treatments Your Healthcare Provider Might Recommend if You Are Sick | CDC​​​